Examples of 'laquinimod' in a sentence
Meaning of "laquinimod"
laquinimod (adjective) - relating to or characteristic of the drug Laquinimod, which is under investigation for potential treatment of autoimmune diseases like multiple sclerosis
Show more definitions
- An experimental immunomodulator being investigated as an oral treatment for multiple sclerosis.
How to use "laquinimod" in a sentence
Basic
Advanced
laquinimod
Insight into the mechanism of laquinimod action.
The effects of laquinimod on lupus arthritis have not been reported.
To evaluate the pharmacokinetics of siponimod and laquinimod.
The mechanism of action of laquinimod is not fully understood.
A combination comprising siponimod and laquinimod.
The precise way in which laquinimod works is unclear.
Meglumine appears to be acting to reduce the oxidation of laquinimod.
The effects of laquinimod on lupus nephritis have not been reported.
A pharmaceutically acceptable salt of laquinimod can be used.
Laquinimod is an immune function modulator.
Treatment of lupus nephritis using laquinimod.
Stable laquinimod preparations.
Nerventra is a medicine that contains the active substance laquinimod.
Disclosed is a process for the preparation of laquinimod sodium which addresses this.
The effects of laquinimod in combination with methotrexate on rheumatoid arthritis have not been reported.
See also
Treatment of rheumatoid arthritis with a combination of laquinimod and methotrexate.
The subject invention also provides laquinimod sodium prepared by any one of the disclosed processes.
Patients are randomized to receive either a combination of siponimod and laquinimod or placebo.
The ability of laquinimod to increase BDNF levels is unexpected.
Yet a further aspect of the invention relates to a combination comprising siponimod and laquinimod.
Laquinimod is also effective in increasing BDNF levels in the patients.
The recovery from neurological paralysis was significantly greater than either laquinimod or siponimod monotherapy.
The relationship between laquinimod and BDNF has not been reported.
Laquinimod was generally safe and well-tolerated.
Discussion The use of meglumine reduces the degradation of the laquinimod sodium in a formulation.
Safety and tolerability of laquinimod were similar to ALLEGRO with no signal of immunosuppression.
Treatment of huntington 's disease using laquinimod.
Studies have shown laquinimod to reduce development of active MRI lesions in relapsing MS.
In another embodiment, the pharmaceutically acceptable salt of laquinimod is laquinimod sodium.
The effect of laquinimod was significantly reduced in the LLF-mice.
In one embodiment, the pharmaceutically acceptable salt of laquinimod is laquinimod sodium.
In one embodiment, the laquinimod is in the form of laquinimod sodium.
In one embodiment, the subject is receiving methotrexate therapy prior to initiating laquinimod therapy.
Joint inflammation was significantly reduced with laquinimod treatment at 5 mg / kg compared to vehicle.
Determining laquinimod in human plasma by liquid chromatography / tandem mass spectrometry.
The data suggest a BDNF-dependent mechanism of action for laquinimod in autoimmune demyelination.
In one embodiment, the laquinimod is administered as monotherapy for relapsing-remitting multiple sclerosis.
In one embodiment, the subject is receiving mycophenolate mofetil therapy prior to initiating laquinimod therapy.
After a month, the amount of laquinimod is determined in the formulations in both containers.
Disclosed is a method of treating Crohn 's disease using laquinimod.
The effects of laquinimod on Crohn 's disease have not been reported.
Embodiment 2, A combination comprising siponimod and laquinimod for the use as a medicament.
Determining Laquinimod in plasma by coupled-column liquid chromatography with ultraviolet absorbance detection.
This study evaluates the efficacy of laquinimod in the MRL / lpr lupus mouse model.
Laquinimod is currently under investigation for the treatment of multiple sclerosis Burton et al ., Curr.
Relationship between PGx and response to laquinimod in terms of clinical, MRI and safety parameters.
Example 5, Laquinimod Sodium Formulations packaged in containers with Oxygen absorbing agent.
Disclosed is a method of treating a subject afflicted with lupus, specifically, lupus arthritis, using laquinimod.
This study confirms that laquinimod abrogated disease progression in NZB / W mice as measured by proteinuria.
Embodiment 3, A combination comprising siponimod and laquinimod.
